AADR vs ARKG

Both AADR and ARKG are ETFs. AADR has a lower 5-year return than ARKG (8.44% vs 33.02%). AADR has a higher expense ratio than ARKG (1.1% vs 0.75%). Below is the comparison between AADR and ARKG.

AADR ARKG
Segment Equity: Global Ex-U.S. - Total Market Growth Equity: Global Biotech
Issuer AdvisorShares ARK
Net Assets $69.25M $886.97M
Expense Ratio 1.10% 0.75%
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.68% 2.53%
Underlying Index -- --
YTD Return 6.98% 128.07%
1-Year Return 15.26% 146.67%
3-Year Return 1.04% 50.31%
5-Year Return 8.44% 33.02%
10-Year Return 7.90% N/A

AADR description

The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.

AADR performance & returns

YTD Return 6.98%
1-Month Return -0.31%
3-Month Return 1.75%
1-Year Return 15.26%
3-Year Return 1.04%
5-Year Return 8.44%
10-Year Return 7.90%
AADR expense ratio is 1.1%.

AADR holdings

Top 10 Holdings (46.22% of Total Assets)

Name Symbol % Assets
MercadoLibre Inc MELI.SA 5.89%
argenx SE ADR ARGX 5.63%
NICE Ltd ADR NICE 5.45%
Gold Fields Ltd ADR GFI.JO 5.07%
Galapagos NV ADR GLPG 4.76%
Anglogold Ashanti Ltd ADR AU.JO 4.67%
ZTO Express (Cayman) Inc ADR ZTO 4.27%
TAL Education Group ADR TAL 3.75%
ASML Holding NV ADR ASML 3.67%
AstraZeneca PLC ADR AZN.L 3.06%

Other relevant AADR comparisons

You may also want to check out the following AADR comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

ARKG description

The Fund seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary.

ARKG performance & returns

YTD Return 128.07%
1-Month Return 7.12%
3-Month Return 22.40%
1-Year Return 146.67%
3-Year Return 50.31%
5-Year Return 33.02%
10-Year Return N/A
ARKG expense ratio is 0.75%.

ARKG holdings

Top 10 Holdings (53.10% of Total Assets)

Name Symbol % Assets
Invitae Corp NVTA 12.01%
CRISPR Therapeutics AG CRSP 8.05%
Pacific Biosciences of California Inc PACB 5.64%
Twist Bioscience Corp TWST 4.71%
Arcturus Therapeutics Holdings Inc ARCT 4.71%
Compugen Ltd CGEN 4.42%
Seres Therapeutics Inc MCRB 3.68%
Iovance Biotherapeutics Inc IOVA 3.48%
Teladoc Health Inc TDOC 3.26%
Personalis Inc PSNL 3.14%

Other relevant ARKG comparisons

You may also want to check out the following ARKG comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.

7-day free trial: Get unlimited comparisons, and stock, ETF and mutual fund analyses for just $15 a month, without ads. Start a free trial. Go ad free!

Follow Us